Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEURO-EMPA: Empagliflozin in Prehypertension
NCT07799441Phase 4Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in prehypertension. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
empagliflozin
03
Conditions
prehypertension
Beyond the preview
Go deeper on NCT07799441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07799441.